IndraLab

Statements


HSP90 inhibitors leads to the methylation of CDKN2A. 1 / 1
| 1

reach
"HSP90 inhibitors also disrupt the DNMT-1 (DNA methyltransferases)/HSP90 interaction and thus abolish the methylation of the CDKN2A locus [78]."